Sugi Predict

Sugi Predict / Compounds / SCHEMBL21692574

SCHEMBL21692574

SCHEMBL21692574

N#Cc1cccc(-c2cc(-c3ccc4sc5ccccc5c4c3)cc(-c3cccc4c3sc3ccc(C#N)cc34)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.46
▸ PDK2 Q15119 1/20 0.37
▸ MAP4K4 O95819 1/20 0.36
▸ ADRA2C P18825 1/20 0.36
▸ CHEK1 O14757 1/20 0.36
▸ GABRG2 P18507 2/20 0.34
▸ GABRB3 P28472 2/20 0.34
▸ GABRA5 P31644 2/20 0.34
▸ GABRA3 P34903 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ CYP1A2 P05177 2/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ CLK4 Q9HAZ1 2/20 0.34
▸ PRKDC P78527 1/20 0.34
▸ PTPN5 P54829 1/20 0.34
▸ PARP14 Q460N5 1/20 0.34
▸ ADORA2A P29274 1/20 0.34
▸ XDH P47989 1/20 0.33
▸ SLC22A12 Q96S37 1/20 0.33
▸ USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21692581 1.00 ALOX5 (0.46) ALOX5PDK2MAP4K4ADRA2CCHEK1
SCHEMBL21691687 0.98 ALOX5 (0.48) ALOX5PDK2MAP4K4ADRA2CCHEK1
SCHEMBL21692333 0.96 ALOX5 (0.46) ALOX5PDK2MAP4K4ADRA2CCHEK1
SCHEMBL21692607 0.96 ALOX5 (0.44) ALOX5PDK2MAP4K4ADRA2CCHEK1
SCHEMBL21692605 0.96 ALOX5 (0.44) ALOX5PDK2MAP4K4ADRA2CCHEK1
SCHEMBL21692375 0.92 ALOX5 (0.47) ALOX5PDK2MAP4K4CHEK1GABRG2
SCHEMBL21691710 0.92 ALOX5 (0.49) ALOX5PDK2MAP4K4ALDH1A1PRKDC
SCHEMBL21691673 0.92 ALOX5 (0.49) ALOX5PDK2MAP4K4PRKDCPARP14
SCHEMBL21693066 0.92 ALOX5 (0.50) ALOX5PDK2MAP4K4ADRA2CCHEK1
SCHEMBL21691790 0.91 ALOX5 (0.39) ALOX5PDK2MAP4K4ADRA2CCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-07-06 — — US disclosed
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG SDI CO., LTD. (KR) 2020-01-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound CCNL2, ARL1, CRY1 ALOX5 2220/4885PDK2 1990/4885MAP4K4 3404/4885
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CCNL2, ARL1, CRY1 ALOX5 2220/4885PDK2 1990/4885MAP4K4 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.